GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CDXS · Jun 30, 2026

CODEXIS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001200375-26-000019General Corporate
Debt relative to revenue67thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.debt_to_revenue

274.06% · OPTIONAL · VALID

Capex intensity30thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

6.02% · OPTIONAL · VALID

Operating cash generation80thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-64.65% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-2.69% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure30thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

10.74% · OPTIONAL · VALID

Gross margin60thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.gross_margin

76.45% · CORE · VALID

Operating margin70thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.operating_margin

-75.29% · CORE · VALID

R&D intensity40thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

78.48% · OPTIONAL · VALID

SBC intensity10thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

10.61% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20250/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
265.50%
Current
274.06%
Delta
8.56%
Capex Intensity Increased
Previous
1.15%
Current
6.02%
Delta
4.87%
Cash Generation Increased
Previous
-86.24%
Current
-64.65%
Delta
21.59%
Growth Decreased
Previous
102.15%
Current
-2.69%
Delta
-104.84%
Inventory Pressure Decreased
Previous
13.12%
Current
10.74%
Delta
-2.38%
Margin Decreased
Previous
86.46%
Current
76.45%
Delta
-10.01%
Profitability Decreased
Previous
-52.75%
Current
-75.29%
Delta
-22.54%
R And D Intensity Increased
Previous
75.08%
Current
78.48%
Delta
3.40%
Sbc Intensity Increased
Previous
9.37%
Current
10.61%
Delta
1.25%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Compared To · Industrial Organic Chemicals peers →Transitioned To · CDXS Fundamental State →Transitioned To · CDXS BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · CDXS CAPEX_INTENSITY_INCREASED →Transitioned To · CDXS CASH_GENERATION_INCREASED →Transitioned To · CDXS GROWTH_DECREASED →Transitioned To · CDXS INVENTORY_PRESSURE_DECREASED →Transitioned To · CDXS MARGIN_DECREASED →Transitioned To · CDXS PROFITABILITY_DECREASED →Transitioned To · CDXS R_AND_D_INTENSITY_INCREASED →Transitioned To · CDXS SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.